Organic compounds -- part of the class 532-570 series – Organic compounds – Cyclopentanohydrophenanthrene ring system containing
Reexamination Certificate
2006-11-14
2006-11-14
Qazi, Sabiha (Department: 1616)
Organic compounds -- part of the class 532-570 series
Organic compounds
Cyclopentanohydrophenanthrene ring system containing
C552S519000, C552S614000, C552S522000, C552S618000, C552S628000
Reexamination Certificate
active
07135581
ABSTRACT:
Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering derivatives of 2-methoxyestradiol of the general formula:wherein the variables are defined in the specification.
REFERENCES:
patent: 2584271 (1952-02-01), Huffman
patent: 2846453 (1958-08-01), Hoehn
patent: 3166577 (1965-01-01), Ringold et al.
patent: 3410879 (1968-11-01), Smith et al.
patent: 3470218 (1969-09-01), Farah
patent: 3492321 (1970-01-01), Crabbe
patent: 3496272 (1970-02-01), Kruger
patent: 3562260 (1971-02-01), De Ruggieri et al.
patent: 3950437 (1976-04-01), Imamura et al.
patent: 3956348 (1976-05-01), Hilscher
patent: 4172132 (1979-10-01), Draper et al.
patent: 4212864 (1980-07-01), Tax
patent: 4307086 (1981-12-01), Tax
patent: 4444767 (1984-04-01), Torelli et al.
patent: 4522758 (1985-06-01), Ward et al.
patent: 4552758 (1985-11-01), Murphy et al.
patent: 4634705 (1987-01-01), DeBernardis et al.
patent: 4743597 (1988-05-01), Javitt et al.
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 4994443 (1991-02-01), Folkman et al.
patent: 5001116 (1991-03-01), Folkman et al.
patent: 5135919 (1992-08-01), Folkman et al.
patent: 5504074 (1996-04-01), D'Amato et al.
patent: 5521168 (1996-05-01), Clark
patent: 5621124 (1997-04-01), Seilz et al.
patent: 5629340 (1997-05-01), Kuwano et al.
patent: 5639725 (1997-06-01), O'Reilly et al.
patent: 5643900 (1997-07-01), Fotsis et al.
patent: 5661143 (1997-08-01), D'Amato et al.
patent: 5716981 (1998-02-01), Hunter et al.
patent: 5733876 (1998-03-01), O'Reilly et al.
patent: 5763432 (1998-06-01), Tanabe et al.
patent: 5776704 (1998-07-01), O'Reilly et al.
patent: 5792845 (1998-08-01), O'Reilly et al.
patent: 5837682 (1998-11-01), Folkman et al.
patent: 5854205 (1998-12-01), O'Reilly et al.
patent: 5854221 (1998-12-01), Cao et al.
patent: 5861372 (1999-01-01), Folkman et al.
patent: 5885795 (1999-03-01), O'Reilly et al.
patent: 5892069 (1999-04-01), D'Amato et al.
patent: 5958892 (1999-09-01), Mukhopadhyay et al.
patent: 6011023 (2000-01-01), Clark et al.
patent: 6046186 (2000-04-01), Tanabe et al.
patent: 6051726 (2000-04-01), Sachdeva et al.
patent: 6054598 (2000-04-01), Sachdeva et al.
patent: 6136992 (2000-10-01), Ram et al.
patent: 6200966 (2001-03-01), Stewart
patent: 6239123 (2001-05-01), Green et al.
patent: 6284789 (2001-09-01), LaLonde et al.
patent: 6358940 (2002-03-01), Conney
patent: 6399773 (2002-06-01), Liu et al.
patent: 6407086 (2002-06-01), Faarup et al.
patent: 6410029 (2002-06-01), Mukhopadhyay et al.
patent: 6514971 (2003-02-01), Thomas et al.
patent: 6528676 (2003-03-01), D'Amato et al.
patent: 6605622 (2003-08-01), Green et al.
patent: 6730665 (2004-05-01), Maran et al.
patent: 6930128 (2005-08-01), D'Amato et al.
patent: 2002/0035098 (2002-03-01), Slaga et al.
patent: 2002/0068724 (2002-06-01), Slaga et al.
patent: 2003/0027803 (2003-02-01), Slaga et al.
patent: 2003/0036539 (2003-02-01), Slaga et al.
patent: 2004/0053906 (2004-03-01), Slaga et al.
patent: 2005/0014737 (2005-01-01), Agoston et al.
patent: 2005/0101573 (2005-05-01), Faarup et al.
patent: 1907330 (1969-10-01), None
patent: 2 004 516 (1970-09-01), None
patent: 27 57 157 (1977-12-01), None
patent: 3625315 (1998-01-01), None
patent: 0166937 (1986-08-01), None
patent: 857080 (1960-12-01), None
patent: 857081 (1960-12-01), None
patent: 1570597 (1980-07-01), None
patent: 39-5480 (1939-04-01), None
patent: 41 000100 (1966-01-01), None
patent: 42-928 (1967-01-01), None
patent: 63090763 (1988-04-01), None
patent: 1240038 (1996-10-01), None
patent: WO 87/02367 (1987-04-01), None
patent: WO 88/08002 (1988-10-01), None
patent: WO 90/15816 (1990-12-01), None
patent: WO 93/03729 (1993-03-01), None
patent: WO 93/19746 (1993-10-01), None
patent: WO 95/04535 (1995-02-01), None
patent: WO 98/32763 (1998-07-01), None
patent: WO 98/40398 (1998-09-01), None
patent: WO 99/01142 (1999-01-01), None
patent: WO 99/22728 (1999-05-01), None
patent: WO 99/33858 (1999-07-01), None
patent: WO 99/33859 (1999-07-01), None
patent: WO 99/35150 (1999-07-01), None
patent: WO 00/07576 (2000-02-01), None
patent: WO 00/10552 (2000-03-01), None
patent: WO 00/66095 (2000-11-01), None
patent: WO 00/68246 (2000-11-01), None
patent: WO 01/27132 (2001-04-01), None
patent: WO 01/85755 (2001-11-01), None
Flshman et al., AN CA54:18587f CAOLD.
Fishman Jack, AN CA52:13765i CAOLD.
Cushman et al., AN 1997:436019, HCAPLUS, J. of Medicinal Chemistry (1997), 40(15), 2323-2334.
Aboulwafa et al., Synthesis and evaluation for uterotrophic and antiimplantation activities of 2-substituted estradiol derivatives,Steroids, vol./Iss: 57, pp. 199-204, Apr. 1992.
Blickenstaff et al., Synthesis of Some Analogs of Estradiol,Steroids, vol./Iss: 46(4,5), pp. 889-902, Oct. 1985.
Brandi et al., Bone endothelial cells as estrogen targets (Abstract only),Calcif. Tissue Int. vol./Iss: 53 (5), pp. 312-317, 1993.
Brueggemeier et al., 2-Methoxymethylestradiol: a new 2-methoxy estrogen analogs that exhibits antiproliferative activity and alters tubulin dynamics,Journal of Steroid Biochemistry&Molecular Biology, vol./Iss: 78, pp. 145-156, 2001.
Crabbe, P., Cotton effect on the styrene chromophore (Abstract only),Chem. Ind., vol./Iss: 27, pp. 917-918, 1969.
Dubey et al., Methoxyestradiols Meidate the Antimitogenic Effects of Estradiol on Vascular Smooth Muscle Cells via Estrogen Receptor-Independent Mechanisms,Biochemical and Biophysical Research Communications, vol./Iss: 278, pp. 27-33, 2000.
El-Tombary . Synthesis, Uterotropic, And Antiuterotrophic Activities of Some Estradiol Derivatives Containing Thiadiazole, Thiazoline, and Thiazolidinone Moieties,Arch. Pharm. Pharm. Med. Chem., vol./Iss: 330 (9-10), pp. 295-302, 1997.
Emons et al., Modulation der hypophysaren Sekretion von Luteinisierendem Hormon (LH) durch Ostrogene,Focus MHL, vol./Iss: 3, pp. 221-228, 1986.
Fanchenko et al., Characteristics of the guinea pig uterus estrogen receptor system (Abstract only),Byull.Eksp. Biol. Med., vol./Iss: 85 (4), pp. 467-470, 1978.
Fraser et al., Angiogenesis and its control in the female reproductive system (Abstract only),British Medical Bulletin, vol./Iss: 56 (3), pp. 787-797, 2000.
Gandhi et al., Mannich reaction of estrone,Journal of Indian Chem. Soc., vol./Iss: 39, pp. 306-308, 1962.
Hahnel et al., The Specificity of the Estrogen Receptor of Human Uterus,Journal of Steroid Biochemistry, vol./Iss: 4, pp. 21-31, 1973.
He et al., Novel Cytokine Release Inhibitors. Part II: Steroids,Bioorganic&Medicinal Chemistry Letters, vol./Iss: 8, pp. 2825-2828, 1998.
Hejaz et al., Synthesis and Biological Activity of the Superestrogen (E)-17Oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: X-ray Crystal Structure of (E)-17-Oximino-3-hydroxy-1,3,5(10)-estratriene,Journal of Medicinal Chemistry, vol./Iss: 42 (16), pp. 3188-3192, 1999.
Holker et al., The Reactions of Estrogens with Benzeneseleninic Anhydride and Hexamethyldisilazane,J. Chem. Soc. Perkin Trans., vol./Iss: 1, pp. 1915-1918, 1982.
Hu, G. Neomycin inhibits angiogenin-induced angiogenesis (Abstract only)Proceedings of the National Academy of Sciences, USA, vol./Iss: 95(17), pp. 9791-9795, 1998.
Ikegawa et al., Immunoaffinity extraction for liquid chromatographic determination of equilin and its metabolites in plasma (Abstract only),Biomed. Chromatogr., vol./Iss: 10 (2), pp. 73-77, 1996.
Iriarte et al., Steroids (XCIV). Synthesis of 2-methyl and 1,2-dimethyl estrogens (Abstract only),Tetrahedron, vol./Iss: 3, pp. 28-36, 1958.
Jaggers et al., Potent Inhibitory effects of steroids in an in vitro model of angiogenesis (Abstract only),Journal of Endocrinology, vol./Iss: 150 (3), pp. 457-464, 1996.
Kovacs et al., Steroids. XXIII. Synthesis of 2- and 4-hydroxy and 2,4-dihydroxy derivatives of estrone and estradiol (Abstract only),Acta Phys.Chem., vol./Iss: 19 (3), pp. 287-290, 1973.
Kurebayashi et al., Paradoxical hormone responses KPL-1 breast cancer cells in vivo: a significant role of angiogenesis in tumor growth (Abstract only),Oncology, vol./Iss: 59 (2), pp. 158-165, 2000.
Lippert et al., The effects of A-ring and D-ring metabolites of estradiol on the prolifera
Agoston Gregory E.
Green Shawn J.
Herbstritt Christopher J.
Hunsucker Kimberly A.
LaVallee Theresa M.
Entremed, Inc.
Kilpatrick & Stockton LLP
Qazi Sabiha
LandOfFree
Antiangiogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiangiogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiangiogenic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3703916